Changes in the partial pressure of arterial carbon dioxide (P a CO 2 ) play a major role in cerebral blood flow (CBF) regulation 1 . Elevations in P a CO 2 (hypercapnia) lead to vasodilatation of cerebral arterioles and subsequent increase in CBF, whereas reductions in P a CO 2 (hypocapnia) lead to vasoconstriction and a decrease in CBF 1 . Measurement of cerebrovascular reactivity to CO 2 has been applied in clinical practice to evaluate cerebrovascular function (e.g. in patients with carotid artery stenosis 2 , hypertension 3 , stroke 4 , heart failure 5 ) and a related impairment has been linked to cerebral ischaemic events 4 .
In patients, prior to coronary artery bypass surgery (CABG), coronary artery disease (CAD) is associated with cognitive impairment 6 and reductions in regional cerebral perfusion 7 . Such changes are likely to worsen with age 8 . Myocardial infarction is also associated with an immediate and long-term elevation in stroke risk 9 . Although the mechanisms underlying these findings are unknown, several risk factors for stroke are associated with reductions in cerebral vasomotor and tissue blood flow. Surprisingly however, no studies have determined cerebrovascular CO 2 reactivity in patients with CAD. In this study, we tested the hypothesis that cerebrovascular reactivity to CO 2 would be impaired SUMMARy Alterations in cerebrovascular reactivity to CO 2 , an index of cerebrovascular function, have been associated with increased risk of stroke. We hypothesised that cerebrovascular reactivity is impaired with increasing age and in patients with symptomatic coronary artery disease (CAD) . Cerebrovascular and cardiovascular reactivity to CO 2 was assessed at rest and during hypercapnia (5% CO 2 ) and hypocapnia (hyperventilation) in subjects with symptomatic CAD (n=13) and age-matched old (n=9) and young (n=20) controls without CAD. Independent of CAD, reductions in middle cerebral artery blood velocity (transcranial Doppler) and cerebral oxygenation (near-infrared spectroscopy) were correlated with increasing age (r=-0.68, r=-0.51, respectively, P <0.01). In CAD patients, at rest and during hypercapnia, cerebral oxygenation was lower (P <0.05 vs young). Although middle cerebral artery blood velocity reactivity was unaltered in the hypercapnic range, middle cerebral artery blood velocity reactivity to hypocapnia was elevated in the CAD and age-matched controls (P <0.01 vs young), and was associated with age (r=0.62, P <0.01). Transient drops in arterial PCO 2 occur in a range of physiological and pathophysiological situations, therefore, the elevated middle cerebral artery blood velocity reactivity to hypocapnia combined with reductions in middle cerebral artery blood velocity may be important mechanisms underlying neurological risk with aging. In CAD patients, additional reductions in cerebral oxygenation may place them at additional risk of cerebral ischaemia. Anaesthesia in patients with severe CAD awaiting CABG when compared with both an age-matched control group and a young, healthy control group. To test this hypothesis, we combined transcranial Doppler to assess middle cerebral artery blood velocity (MCAv) and near-infrared spectroscopy (NIRS) for the monitoring of local cerebral oxygenation during step changes in P a CO 2 . Transcranial Doppler provides a direct measure of blood flow velocity, whereas NIRS provides activation-dependent information. The combination of NIRS and MCAv provides complementary information for the evaluation of cerebral haemodynamic function.
MATERIALS AND METHODS

Subjects
Forty-two subjects volunteered for this study and were divided into three groups: 1) those with symptomatic CAD (n=13), 2) age-matched controls without CAD (n=9) and 3) young control group (n=20). The participants' characteristics are outlined in Table 1 . All participants underwent a routine medical history and physical examination and were screened with two-dimensional transthoracic echocardiography to assess both left ventricular function and the presence of valvular abnormalities. The CAD patient group either had a recent myocardial infarction (proven by 12-lead electrocardiogram changes or serum troponin-T elevation) or anginal symptoms necessitating hospital admission. All patients in the CAD group had angiographically confirmed severe CAD and were awaiting CABG. Exclusion criteria included: 1) a history of a cerebrovascular events or carotid artery disease as assessed by duplex ultrasound, 2) aortic stenosis as assessed by transthoracic echocardiography, 3) clinical instability as determined by the primary medical team or 4) the use of intravenous vasoactive drugs for relief of ongoing chest pain.
This study was approved by the Lower South Island Regional Ethics Committee. Participants were provided with written and verbal descriptions of the experimental protocol and written informed consent was obtained.
Experimental design
Participants arrived at the laboratory having abstained from exercise, alcohol and caffeine for 24 hours. They were also instructed against eating a heavy meal for at least four hours prior to the experiment.
Measurements of cerebral blood flow velocity, arterial blood pressure and end-tidal CO 2
Measurements were performed with subjects in the supine position following a minimum of 15 minutes of rest. Blood flow velocity in the right or left middle cerebral artery was measured using a 2 MHz pulsed Doppler ultrasound system (DWL Doppler, Sterling, vA, USA). The right middle cerebral artery was used preferentially, but in three participants the left middle cerebral artery was used because the right signal was of poor quality. The position and angle of the Doppler probe was secured with a headband device (Spencer Technologies, Nicolet Instruments, Madison, USA). Beat-to-beat arterial blood pressure was monitored using finger photoplethysmography (Finometer, TPD Biomedical Instrumentation, Netherlands). Cerebral vascular resistance was calculated by dividing mean blood pressure by mean MCAv. Heart rate, stroke volume and cardiac output were calculated from the blood pressure waveform using the Model Flow method (BeatScope 1.0 software, TNO TPD, Biomedical Instruments, Netherlands). This method provides a reliable estimate of changes in cardiac output 10 . Automated blood pressure recordings were intermittently used to confirm the accuracy of the finger photoplethysmography measurements. End-tidal CO 2 was sampled from a leak-free mask and measured by a gas analyser (model CD-3A CO 2 analyser, AEI Technologies, Pittsburgh, PA, USA).
Cerebral oxygenation
Frontal cortical oxygenation was monitored noninvasively using NIRS (NIRO-200, Hamamatsu Photonics KK, Hamamatsu, Japan). A probe-holder containing an emission probe and detection probe was attached at the right side of the forehead with a distance of 5 cm between the probes. The methodology of this system has been described previously 11 . The optodes were housed in an optically dense plastic holder secured on the skin with tape to minimise extraneous light. Local oxygenation was measured simultaneously every second throughout the experiment. All data were acquired continuously at 200 Hz using an analog-to-digital converter (Powerlab/16SP ML795, ADInstruments, Colorado Springs, CO, USA) interfaced with a computer and were subsequently analysed using commercially available software (Chart version 5.02, ADInstruments).
Hyper-and hypocapnic cerebrovascular reactivity
Hypercapnia was induced by switching the inspired gas from room air to 5% CO 2 (in 21% O 2 and N 2 balance) for three to four minutes. Following the hypercapnia, subjects were permitted a brief recovery and were then instructed to increase their rate and depth of breathing to reduce P ET CO 2 to 16 to 18 mmHg. verbal feedback was provided to assist subjects to reach and maintain the target levels of hyperventilation. The hypercapnic condition was always conducted first because prior hypocapnia (but not prior hypercapnia) has been shown to produce prolonged effects on vascular tone, thus influencing the normal MCAv-CO 2 response to hypercapnia 12 . The last minute of each exposure was used for data analysis. The hypercapnic or hypocapnic cerebral vascular reactivity was characterised as the slope of the linear regression fitted to the percentage change in MCAv from baseline per mmHg increase in P ET CO 2 .
Analytical measurements
Arterial and venous blood gases were obtained at rest using a 25 gauge needle into a pre-heparinised syringe with the subject in the supine position after 25 minutes of rest. Immediately after acquisition, the samples were transferred to capillary tubes for measurement of blood gases, haemoglobin and haematocrit (NPT™7 Series, Radiometer, Copenhagen, Denmark). Commercial standards were used to calibrate the blood gas analyser before starting the tests.
Statistical and data analysis
All data were analysed using SPSS statistical software (SPSS version 15.0, SPSS Inc, Chicago, IL, USA). One-way analysis of variance was used to assess the statistical differences following interventions, with the Bonferroni-Dunn test used for post hoc analysis when a significant effect was found. A Pearson correlation analysis was used to determine the relationship between selected variables. All group data are expressed as a mean ± standard deviation. Significance was established at an alpha level of P <0.05.
RESULTS
Subjects
Demographic information, concurrent medical conditions and cardiovascular risk factors for the three groups are outlined in Table 1 . Patients with CAD had a recent admission (<30 days) to hospital and 10/13 (79%) were in-patients at the time of testing, reflecting severity of the disease. The majority had New york Heart Association functional class III symptoms and 38% had a documented myocardial infarction less than 30 days prior to testing.
The effects of age and coronary artery disease on resting haemodynamic function
Baseline haemodynamic and respiratory data are outlined in Table 2 . MCAv (mean, systolic and diastolic) was lower in the CAD and old control group (P <0.001 vs young). There was no difference in cerebral oxygenation between the young and old control group, however it was reduced in the CAD group (Table 2 and Figure 1 , P <0.05 CAD vs young). Cerebral vascular resistance was highest in the CAD and old control group (P <0.005 vs young). Independent of CAD, the decline in MCAv and cerebral oxygenation was associated with increasing age (r=-0.68, r=-0.51, respectively, both P <0.01).
Hyper-and hypocapnic cerebrovascular reactivity
No differences were observed between the three groups in MCAv reactivity to hypercapnia. In addition, changes in MCAv reactivity to hypercapnia were not correlated with changes in age (r=0. 13, P=0.43) . MCAv reactivity to hypocapnia however, was elevated in the CAD and old control groups (Figure 2 , P <0.01 vs young) and was correlated with increasing age (r=0.62, P <0.01). There were no between-group differences in MAP-reactivity to hyper-or hypocapnia. Despite MCAv reactivity , old (old healthy controls, age-matched to patients with coronary artery disease) and those with coronary artery disease (CAD). Each data point represents an individual subject, mean standard deviation for each group is shown. While there was no difference in MCAv-CO 2 reactivity to hypercapnia among the three groups, MCAv-CO 2 reactivity to hypocapnia is increased in the old CAD groups (P <0.001 vs young).
to hypercapnia being similar in all three groups, cerebral oxygenation remained lower in patients with CAD (Figure 1 , P <0.05 vs young).
DISCUSSION
The three important findings of this study are: 1) an elevated MCAv-CO 2 response to hypocapnia with age, independent of CAD; 2) a parallel reduction in cerebral oxygenation and MCAv with increasing age and 3) a further selective reduction in cerebral oxygenation in patients with CAD. We propose that the elevated MCAv reactivity to hypocapnia combined with a lower resting MCAv and cerebral oxygenation might be contributory mechanisms underlying the greater risk of ischaemic stroke with increasing age, especially during common situations in which a transient lowering of arterial PCO 2 might occur. This may be of particular relevance in patients with CAD, where additional reductions in cerebral oxygenation may increase their risk of neurological injury.
Cerebrovascular reactivity to CO 2
Consistent with previous reports 5, 13 , MCAv-CO 2 reactivity is greater in the hypercapnic than the hypocapnic range ( Figure 2) . In contrast to these findings, predominately in younger subjects 12, 13 , we report for the first time an age-related elevation in MCAv-CO 2 reactivity in the hypocapnic range. Since this observation persisted in both aged controls and those with CAD, this finding may be contributory to the increased risk of cerebral ischaemia with aging during declines in P a CO 2 . The influence of aging on CO 2 reactivity has been described previously with mixed findings. For example, some studies have reported that the cerebral vasoconstrictive response to hypocapnia and vasodilatory response to hypercapnia are reduced with advancing age 14, 15 , whereas other studies indicate that reactivity is maintained 16, 17 . For instance, one of the largest reported prospective observational studies using transcranial Doppler ultrasound to assess MCAv-CO 2 reactivity in subjects over 55 years of age, in contrast to our current findings, reported that MCAv-CO 2 reactivity to hypercapnia reduced with advancing age 18 . MCAv reactivity in the hypocapnic range was not examined in that study. Moreover, upon closer examination of the findings, it is apparent that there was minimal change in MCAv-CO 2 reactivity in patients aged 55 to 75 years and that the decline in hypercapnic MCAv-CO 2 reactivity occurred mostly in those aged 75 to 90 years. In addition, the technique used to assess reactivity included the use of 5% CO 2 mixed with a 95% O 2 gas mixture. The addition of hyperoxia to the inhaled mixture may have 'masked' the true effects of CO 2 on the cerebral vasculature. It is now well established that hyperoxia can also have a marked influence on CBF. For example, hyperoxia (>60 seconds) is a respiratory stimulant in adults 19 , which results in subsequent reduction in P a CO 2 and accompanying vasoconstriction in the arterioles, reducing CBF 20, 21 . It should also be noted that, in addition to the hyperoxic-induced reduction in P a CO 2 and accompanying vasoconstriction in the arterioles reducing CBF 20, 21 , increases in P a O 2 also have a direct vasoconstrictive effect independently of the P a CO 2 response 20, 22 . Therefore, differences in experimental design (i.e. posture, CO 2 monitoring, pathology, variation in degree of hypercapnia and hypocapnia), methodological assessment of CBF (i.e. xenon-133 inhalation, positron emission tomography, Doppler ultrasonography) degree of related age and pathology (e.g. intracranial atherosclerosis, haemodynamics, embolism etc), may, in part, underline these divergent and variable findings.
It should be acknowledged that medications such as angiotensin-converting enzyme inhibitors and statins may influence normal cerebrovascular responsiveness to changes in P a CO 2 and improve MCAv-CO 2 reactivity to hypercapnia 23, 24 . The use of these medications among patients in the CAD group may have confounded the results (Table1) and may explain why there was no observed difference in MCAv-CO 2 reactivity during hypercapnia between those with and without CAD. Because of obvious ethical and safety constraints, it was not possible to discontinue medication in our patient group with CAD. Our study was not designed to examine the potential influence of the necessary medications in patients with CAD. However, an understanding of how these medications independently, synergistically and probably antagonistically act on the regulation of CBF would be highly desirable from a clinical perspective and would be a worthwhile avenue for future research.
From a teleological perspective however, the 'normal' lower reactivity in the hypocapnic range compared to the hypercapnic range might be a protective mechanism to prevent cerebral ischaemia during transient drops in P a CO 2 , which are known to occur in a range of physiological (postural change, exercise) and pathophysiological (asthma, syncope, sleep apnoea, congestive heart failure, anxiety) situations. Our findings indicate that this protective response to hypocapnia might decline with age, independently of CAD. While acknowledging that the mechanisms underlying these potential differences in MCAv-CO 2 reactivity were not established in the current study, it seems reasonable to speculate that the balance of vasodilator and vasoconstrictive mediators 25 on intracranial vascular tone might be altered with age, per se, and from the medication associated with treatment of CAD.
Cerebral blood flow, cerebral oxygenation and age
Our observed decline in MCAv with age is consistent with previous reports of reductions in total CBF, as assessed using a variety of imaging techniques 8, 26 . These studies collectively indicate that, because aging is associated with global cerebral atrophy, the observed decreases in CBF reflect a global decrease in cerebral perfusion, without any disturbance of regional perfusion or oxygen consumption. To the best of our knowledge, the finding of a greater reduction in cerebral oxygenation at rest and during hypercapnia in patients with CAD is novel. It is of interest to note that this selective impairment in cerebral oxygenation in patients with CAD occurred despite a 'normal' age-related MCAv-CO 2 reactivity. Consistent with these findings is an early report which demonstrated that the hyperfrontal distribution of CBF-CO 2 reactivity (assessed using the xenon-133 inhalation technique) observed in younger healthy subjects (mean age 24 years) was absent in older healthy subjects (mean age 62 years) 15 .
It should be noted that, compared to the young and old group, the patients with CAD and poor New york Heart Association status were relatively more hypoxaemic ( Table 1) . As a result, this may partly lead to a compromise in oxygenation of all tissues, including the brain. Nevertheless, it is known that a fall in P a O 2 to below approximately 40 mmHg is required to produce cerebral vasodilatation 27 . Thus it would seem unlikely that the relatively mild hypoxaemia (84±11 mmHg) in the CAD patients would cause any increase in MCAv.
Regardless of the underlying mechanisms, in a number of clinical settings, reductions in cerebral oxygenation measured by NIRS have been shown to correlate with increased incidence of neurological events and mortality 28 . In patients undergoing CABG, intraoperative cerebral desaturations correlate with increased incidence of postoperative reduction in neurocognitive function 29 and of stroke 30 . Whether the degree of preoperative reduction in cerebral oxygenation influences clinical outcome remains to be established, however a recent report indicates that a decrease in cerebral tissue oxygen index, as assessed using NIRS, of approximately 13% is required to reach a 'threshold' of cerebral ischaemia 31 .
Therefore, in patients with CAD, reduction in cerebral oxygenations, combined with reductions in MCAv and an elevated MCAv-CO 2 response to hypocapnia may be important mechanisms underlying the risk of ischaemic neurological events. It was noteworthy, however, that despite an exaggerated MCAv response to hypocapnia, cerebral oxygenation was maintained at this point. This maintained cerebral oxygenation likely reflects the fact that cerebral oxygenation is not only influenced by CBF but also the balance between venous and arterial oxygen saturation 27 . Therefore, upon voluntary hyperventilation to induce the hypocapnia, there would also have been related increase in arterial oxygenation saturation (which may be even larger in the CAD group given the greater degree of hypoxaemia observed). Indeed, the voluntary hyperventilation needed to reduce P ET CO 2 to 16-18 mmHg is much greater than that induced by the hypercapnic (5%) stimulus 27 . Maintainence of cerebral oxygenation despite reduction in CBF is also seen during administration of 100% oxygen: CBF falls because of hyperoxia-induced hyperventilation and related hypocapnic-induced cerebral vasoconstriction 22 , but cerebral oxygenation is actually increased at this point, presumably because of marked elevations in P a O 2 .
It should be acknowledged that other potential mechanisms were not being investigated in our study and could, therefore, be equally important factors in the development of ischaemic neurological events. In particular, we did not specifically investigate participants for the presence of intracranial atherosclerotic occlusive disease, which would require screening either with invasive cerebral angiography, magnetic resonance angiography or perfusion-weighted magnetic resonance imaging. While we excluded participants with known cerebrovascular disease or carotid artery stenosis from the current study, we acknowledge that the presence of 'silent' cerebrovascular occlusive disease was not investigated. In particular, the group with CAD, by virtue of their vascular disease, may have a higher incidence of small vessel cerebrovascular disease that is not clinically apparent. It can be hypothesised, therefore, that some of the changes we observed, in particular the reduction in MCAv and cerebral oxygenation, may be, in part, due to the presence of silent cerebrovascular disease in some of the subjects studied.
Methodological considerations
Although transcranial Doppler ultrasound measures flow velocity, rather than blood flow, in the MCA, the majority of research suggests that MCAv is a reliable index of regional CBF, due to little or no change in the diameter of the MCA 32, 33 . The NIRS monitors oxygenation in tissue and confirms the capillary oxygen level-dependent related increase in oxygenation observed by functional magnetic resonance imaging during neural activation 34 . We acknowledge that NIRS measures only local (i.e. to one depth) oxygenation and that discreet regions of the brain may respond differently during acute changes in P a CO 2 .
In conclusion, the enhanced MCAv reactivity to hypocapnia combined with a lower MCAv and cerebral oxygenation may be important mechanisms leading to neurological injury with ageing. These may be particularly important in patients with CAD who show additional reductions in cerebral oxygenation at rest and during hypercapnia.
